abstract |
The present invention relates to at least one L-type calcium channel blocker, in particular (+)-isopropyl 2-methoxyethyl 4- (2-chloro-3-cyano-phenyl) -1,4-dihydro-2,6-dimethyl-pyridine. It relates to a composition comprising a compound of 3,5-dicarboxylate in combination with at least one cholinesterase inhibitor, in particular donepezil, and its use in a method of treatment. |